Survival of C28Y homozygotes does not preclude screening for HFE mutations

Gavin Willis, Barbara A. Jennings, Jennie Z. Wimperis

Research output: Contribution to journalComment/debate

44 Citations (Scopus)


In their recent paper, Coppin et al [1] found surviving elderly C282Y homozygotes at a frequency similar to our previous study [2]. Their results illustrate clearly and simply that fatal disease is not an invariant outcome for untreated female C282Y homozyogotes and our previous study drew the same conclusion for male C282Y homozygotes.
Original languageEnglish
Article number132
JournalBMJ-British Medical Journal
Publication statusPublished - 22 Jul 2003

Cite this